Revenue
2018
2019
2020
2021
2022
2023
2024
2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B | $1.37B | $1.52B | $1.47B | $1.19B | $992.1M | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | $851.0M | $952.9M | $900.9M | $752.7M | $643.0M | $556.2M | $493.8M | — | — | — | — | — | — |
| Research & development | $99.0M | $115.4M | $104.2M | $101.2M | $93.1M | $77.4M | $79.6M | $78.0M | $63.5M | $58.2M | $50.9M | $43.6M | $42.6M | $51.0M | $51.5M | $48.1M | $44.3M | $60.5M |
| Operating income | −$493.4M | $28.4M | $111.5M | $238.9M | $197.2M | $151.4M | $93.8M | $111.0M | $44.8M | $115.3M | $79.6M | $67.9M | $35.4M | $73.8M | $54.9M | $98.7M | $97.8M | $47.4M |
| EBITDAderived | −$433.6M | $92.1M | $164.8M | $292.9M | $253.5M | $221.2M | $203.2M | $221.7M | $133.7M | $188.0M | $138.4M | $114.3M | $66.4M | $126.4M | $105.1M | $137.9M | $137.5M | $78.1M |
| Net income | −$516.5M | −$6.9M | $67.7M | $180.6M | $169.1M | $133.9M | $50.2M | $60.8M | $64.7M | $74.6M | −$3.5M | $34.0M | −$21.1M | $41.2M | $28.0M | $65.7M | $51.0M | $27.7M |
| Basic EPSper diluted share | -$6.74 | -$0.09 | $0.85 | $2.18 | $2.00 | $1.58 | $0.59 | $0.73 | $0.84 | $1.00 | -$0.05 | $0.52 | -$0.74 | $1.46 | $0.97 | $2.21 | $1.75 | $0.98 |
| Diluted EPSper diluted share | -$6.74 | -$0.09 | $0.84 | $2.16 | $1.98 | $1.57 | $0.58 | $0.72 | $0.82 | $0.94 | -$0.05 | $0.52 | -$0.74 | $1.44 | $0.95 | $2.17 | $1.74 | $0.96 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 5, 2025Form 4 | GRAVES JEFFREY ADirector | BuyCommon Stock | 9.0K | $11.35 | $102.2K | 41.1K |
| Dec 3, 2024Form 4 | Schwartz EricEVP, Chief Legal Officer & Sec | SellCommon Stock | 4.1K | $24.60 | $100.1K | 59.5K |
| Dec 2, 2024Form 4 | McBreen Michael J.EVP & President, CSS | SellCommon Stock | 1.7K | $24.16 | $41.1K | 56.2K |
| Aug 19, 2024Form 4 | Mosebrook JeffreySVP, Fin & Princ Acct Officer | SellCommon Stock | 1.2K | $21.58 | $25.7K | 36.1K |